Literature DB >> 24935925

Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.

Mohamad El-Zaatari1, Yu-Ming Chang2, Min Zhang2, Matthew Franz2, Andrew Shreiner2, Andrew J McDermott3, Koenraad F van der Sluijs4, René Lutter5, Helmut Grasberger2, Nobuhiko Kamada2, Vincent B Young3, Gary B Huffnagle3, John Y Kao1.   

Abstract

The interplay between Clostridium difficile and the host's metabolome is believed to influence the severity of infection. However, the mechanism for this phenomenon remains unclear. In this study, we model one of these metabolic pathways by focusing on tryptophan metabolism in the host. We found that inhibition of tryptophan catabolism in IDO1-knockout mice led to increased mucosal destruction, cecal hemorrhage, and increased production of IFN-γ in response to C. difficile infection, but no significant change in mucosal effector or regulatory T cell numbers or IL-10 mRNA expression. The increased immunopathology in infected IDO1-knockout mice was associated with a lower C. difficile burden and an increased percentage of IFN-γ-expressing neutrophils. We further demonstrated the ability of kynurenine to induce apoptosis in bone marrow-derived neutrophils, whereas the presence of tryptophan reversed this effect, providing a possible mechanism for the increased neutrophil accumulation in IDO1(-/-) mice. We conclude that C. difficile induces tryptophan catabolism in cecal lamina propria cells, which restricts C. difficile-associated immunopathology and the accumulation of IFN-γ-expressing neutrophils. This might represent a self-regulatory mechanism for neutrophils, via the IFN-γ-IDO1 pathway, to restrict their own accumulation during infection. These findings have important clinical implications because IDO inhibitors are used to treat cancer in clinical trials (in patients particularly susceptible to getting C. difficile infection), and treatment with IDO1 inhibitors may exacerbate the severity of C. difficile colitis.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935925      PMCID: PMC4091639          DOI: 10.4049/jimmunol.1302913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Indoleamine 2,3-dioxygenase. Purification and some properties.

Authors:  T Shimizu; S Nomiyama; F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

2.  Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Authors:  A L Mellor; J Sivakumar; P Chandler; K Smith; H Molina; D Mao; D H Munn
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

3.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Authors:  Madhav D Sharma; Babak Baban; Phillip Chandler; De-Yan Hou; Nagendra Singh; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

4.  Prevention of allogeneic fetal rejection by tryptophan catabolism.

Authors:  D H Munn; M Zhou; J T Attwood; I Bondarev; S J Conway; B Marshall; C Brown; A L Mellor
Journal:  Science       Date:  1998-08-21       Impact factor: 47.728

5.  Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.

Authors:  Yuko Ishida; Tsuneo Maegawa; Toshikazu Kondo; Akihiko Kimura; Yoichiro Iwakura; Shinichi Nakamura; Naofumi Mukaida
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

6.  Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.

Authors:  O Takikawa; R Yoshida; R Kido; O Hayaishi
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

7.  Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis.

Authors:  Lynne Harrington; Chittur V Srikanth; Reuben Antony; Sue J Rhee; Andrew L Mellor; Hai Ning Shi; Bobby J Cherayil
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.

Authors:  Babak Baban; Phillip Chandler; Doris McCool; Brendan Marshall; David H Munn; Andrew L Mellor
Journal:  J Reprod Immunol       Date:  2004-04       Impact factor: 4.054

9.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

10.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Authors:  Casey M Theriot; Mark J Koenigsknecht; Paul E Carlson; Gabrielle E Hatton; Adam M Nelson; Bo Li; Gary B Huffnagle; Jun Z Li; Vincent B Young
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more
  24 in total

Review 1.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.

Authors:  Emily S Cribas; Joshua E Denny; Jeffrey R Maslanka; Michael C Abt
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

3.  Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.

Authors:  Mohamad El-Zaatari; Adam J Bass; Reanne Bowlby; Min Zhang; Li-Jyun Syu; Yitian Yang; Helmut Grasberger; Andrew Shreiner; Bei Tan; Shrinivas Bishu; Wai K Leung; Andrea Todisco; Nobuhiko Kamada; Marilia Cascalho; Andrzej A Dlugosz; John Y Kao
Journal:  Gastroenterology       Date:  2017-09-11       Impact factor: 22.682

Review 4.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

5.  Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli.

Authors:  Jennifer A Loughman; Melanie L Yarbrough; Kristin M Tiemann; David A Hunstad
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Nicole R Falkowski; Roderick A McDonald; Charles R Frank; Chinmay R Pandit; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2017-01-30       Impact factor: 7.397

7.  Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis.

Authors:  Nicholas O Markham; Sarah C Bloch; John A Shupe; Erin N Laubacher; Audrey K Thomas; Heather K Kroh; Kevin O Childress; F Christopher Peritore-Galve; M Kay Washington; Robert J Coffey; D Borden Lacy
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 8.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

Review 9.  Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections.

Authors:  Shinsmon Jose; Rajat Madan
Journal:  Anaerobe       Date:  2016-04-05       Impact factor: 3.331

10.  Amelioration of Clostridium difficile Infection in Mice by Dietary Supplementation With Indole-3-carbinol.

Authors:  Walker Julliard; Travis J De Wolfe; John H Fechner; Nasia Safdar; Rashmi Agni; Joshua D Mezrich
Journal:  Ann Surg       Date:  2017-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.